On October 6, 2025, OneMedNet announced a multi‑year partnership with Palantir Technologies to deploy its Artificial Intelligence Platform (AIP) across the company’s real‑world data network. The deal will integrate Palantir’s AIP with OneMedNet’s iRWD™ platform, enabling near‑real‑time AI‑powered analytics for life‑science, medical‑device, and research organizations.
Under the agreement, Palantir will provide the infrastructure that gives OneMedNet access to more than 5 billion administrative claims and 131 million clinical exam records from over 1,750 provider sites, covering oncology, cardiology, and rare‑disease specialties. The partnership positions Palantir to capture a share of the $868 billion AI‑driven healthcare market projected for 2030.
The partnership represents a significant customer win for Palantir, expanding its commercial footprint beyond government and defense into a high‑growth, regulated sector. The multi‑year nature of the deal signals long‑term revenue potential and strengthens Palantir’s portfolio of enterprise‑scale AI solutions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.